Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CITALOPRAM HYDROBROMIDE Cause Bursitis? 392 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 392 reports of Bursitis have been filed in association with CITALOPRAM HYDROBROMIDE (Citalopram Hydrobromide). This represents 1.5% of all adverse event reports for CITALOPRAM HYDROBROMIDE.

392
Reports of Bursitis with CITALOPRAM HYDROBROMIDE
1.5%
of all CITALOPRAM HYDROBROMIDE reports
101
Deaths
4
Hospitalizations

How Dangerous Is Bursitis From CITALOPRAM HYDROBROMIDE?

Of the 392 reports, 101 (25.8%) resulted in death, 4 (1.0%) required hospitalization, and 3 (0.8%) were considered life-threatening.

Is Bursitis Listed in the Official Label?

Yes, Bursitis is listed as a known adverse reaction in the official FDA drug label for CITALOPRAM HYDROBROMIDE.

What Other Side Effects Does CITALOPRAM HYDROBROMIDE Cause?

Toxicity to various agents (3,531) Completed suicide (2,319) Drug abuse (1,792) Drug ineffective (1,729) Fatigue (1,431) Overdose (1,377) Drug interaction (1,366) Headache (1,339) Nausea (1,258) Foetal exposure during pregnancy (1,154)

What Other Drugs Cause Bursitis?

ADALIMUMAB (2,448) TOCILIZUMAB (2,094) RITUXIMAB (2,075) METHOTREXATE (2,060) ABATACEPT (1,903) ALENDRONATE (1,873) ETANERCEPT (1,768) SECUKINUMAB (1,755) LEFLUNOMIDE (1,728) CETIRIZINE (1,706)

Which CITALOPRAM HYDROBROMIDE Alternatives Have Lower Bursitis Risk?

CITALOPRAM HYDROBROMIDE vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE vs CITICOLINE CITALOPRAM HYDROBROMIDE vs CITRIC ACID CITALOPRAM HYDROBROMIDE vs CITRIC ACID\LACTIC ACID, L-\POTASSIUM CITALOPRAM HYDROBROMIDE vs CLADRIBINE

Related Pages

CITALOPRAM HYDROBROMIDE Full Profile All Bursitis Reports All Drugs Causing Bursitis CITALOPRAM HYDROBROMIDE Demographics